Adaptive Biotechnologies spinout raising $15M to develop clinical sequencing tech

Digital Biotechnologies Inc., a new Seattle-based subsidiary of publicly traded immune medicine company Adaptive ...
GEN

Semiconductor Sequencing Technology

According to Jonathan M. Rothberg, Ph.D., CEO, founder, and chairman of Ion Torrent, his company’s semiconductor sequencing technology represents a quantum advancement in DNA sequencing. Ion Torrent™ ...
Nasdaq

Quantum-Si’s Next-Generation Single-Molecule Protein Sequencing Technology Published in Science, Signaling New Era of Life Science and Biomedical Research

Semiconductor Chip and Time Domain Sequencing™ Technology Will Advance Drug Discovery and Diagnostics, Enabling People to Live Healthier and Longer Lives Next-generation single-molecule protein ...
Nasdaq

Roche unveils a new class of next-generation sequencing with its novel sequencing by expansion technology

Roche's innovative sequencing by expansion (SBX) technology represents a leap forward in next-generation sequencing (NGS), which is playing a vital role in decoding complex diseases like cancer, ...
GEN

Protein Sequencing Expands the Omics Club

The most exclusive club in omics has admitted only genomics and transcriptomics, the beneficiaries of single-molecule sequencing technologies that are so powerful they enable highly refined ...
PharmiWeb

seqWell Launches AgriPrep™ Library Prep Kit for Low Coverage Whole Genome Sequencing

One-step Library Prep Workflow Designed to Address the Scalability, Performance, and Affordability Needs of Applied ...
news.ucsc

UCSC’s David Deamer and Mark Akeson honored for invention of nanopore sequencing

David Deamer (left) and Mark Akeson in Santa Cruz in 2023 after receiving the inaugural UCSC Chancellor’s Innovation Impact Award for inventing nanopore sequencing. (photo by Today, two UC Santa Cruz ...
Business Wire

Avantor to Distribute Quantum-Si’s Next-Generation Protein Sequencing™ Technology

BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, has ...
Business Wire

Aptorum Therapeutics Limited Enters Into Letter of Intent and Term Sheet with Universal Sequencing Technology Corporation to Merge with Aptorum Group’s Subsidiary Paths ...

NEW YORK & LONDON & PARIS--(BUSINESS WIRE)--Regulatory News: Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) (“Aptorum Group” or “Company”), today announced that its wholly owned subsidiary ...
The Scientist

Revving the Motor: Full-Length Protein Sequencing with Nanopore Technology

Protein sequencing presents different challenges than nucleic acid sequencing, meaning that proteomics has yet to benefit as much as genomics from the next-generation sequencing revolution. However, ...